KATHERINE CREGOR: Open Payments
NPI 1861953630 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$432 in 18 payments from 9 companies in 2025. Trend: 2023 $378 · 2024 $348 · 2025 $432
Food & beverage: $363Education: $69
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $110 |
| GENZYME CORPORATION | 4 | $86 |
| UCB, Inc. | 3 | $59 |
| Amgen Inc. | 3 | $55 |
| Janssen Biotech, Inc. | 2 | $51 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Incyte Corporation | 1 | $18 |
| Sandoz Inc. | 1 | $14 |
| SpringWorks Therapeutics, Inc. | 1 | $14 |
Products named: DUPIXENT, Bimzelx, OTEZLA, TREMFYA, ILUMYA, OPZELURA, HYRIMOZ, GOMEKLI.
Industry payments across KY — which companies pay providers there.
